News | April 06, 2026
Red Nucleus acquires Bridge Medical Consulting with advisory support from VERTICES PARTNERS
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
Company leadership is framing the move as transformational.
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
This marks a meaningful step in the company's continued expansion in the region
Subscribe To Our Newsletter & Stay Updated
